An increase in demand for genetic testing services, coupled with a greater emphasis on preventive healthcare, has positioned consumer genomics as a transformative sector in the healthcare landscape.
Given this backdrop, it could be wise to consider investing in fundamentally strong genomics stocks, Bio-Techne Corporation (TECH), Illumina, Inc. (ILMN), and Exelixis, Inc. (EXEL) which are unlocking the future of medicine.
